Patient Detail: Registration Location: Reference: Patient Number:
Haji Asghar . Doctors Road, Pirmehal Diabetes Care Program 55301-22-10373578
Age/Sex : Registration Date: Consultant: Case Number:
68 (Y) / M 16-Jul-2025 08:51 DR HADI MEERAN HUSSAIN 55311-16-07
Note : Sample Brought to the Lab, , ,
Collection DateTime: 16-Jul-2025 08:51
Department of Hematology Reporting DateTime: 16-Jul-2025 20:17
Blood C/E (Complete, CBC)
55311-16-07
Test Reference Value Unit 16 Jul 2025 08:51
Hb 12.3 - 16.6 g/dl 14.4
Electronically verified report. No signature required. Lab reports should be interpreted by a physician in correlation with clinical and radiologic findings
Total RBC 4.25 - 6.02 x10^12/l 5.3
HCT 38.4 - 50.7 % 46
MCV 78.7 - 96.3 fl 87
MCH 25.1 - 31.6 pg 27
MCHC 30 - 36 g/dl 31
RDW CV % 11.5 - 14.5 % 16.1
Platelet Count 150 - 430 x10^9/l 234
MPV fl 7 - 11 fl 12.9
WBC Count (TLC) 4.8 - 11.3 x10^9/l 8.1
Neutrophils 35.0 - 76.0 % 58.3
Lymphocytes 18.0 - 45.0 % 30.8
Monocytes 4.0 - 10.0 % 9.2
Eosinophils 1.0 - 6.0 % 1.5
Basophils Less Than 1.0 % 0.2
Abs. Neutrophils 2.00 - 7.00 x10^9/l 4.72
Abs. Lymphocytes 1.00 - 3.00 x10^9/l 2.50
Abs. Monocytes 0.20 - 1.00 x10^9/l 0.75
Abs. Eosinophils 0.02 - 0.50 x10^9/l 0.12
Abs. Basophils Less Than 0.11 x10^9/l 0.02
Dr.Mubashar Razzaq Khan
Consultant Pathologist
Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 [email protected] 1 of 1 Saleemi Chowk Satiana Road Faisalabad www.chughtailab.com
Patient Detail: Registration Location: Reference: Patient Number:
Haji Asghar . Doctors Road, Pirmehal Diabetes Care Program 55301-22-10373578
Age/Sex : Registration Date: Consultant: Case Number:
68 (Y) / M 16-Jul-2025 08:51 DR HADI MEERAN HUSSAIN 55311-16-07
Note : Sample Brought to the Lab, , ,
Department of Chemical Pathology Collection DateTime:
Reporting DateTime:
16-Jul-2025 08:51
16-Jul-2025 23:33
9
Glycosylated Hemoglobin (HbA1c)
7.7
8.5
8
7.6 7.7
7.5
%
7
6.5 Diabetes
Electronically verified report. No signature required. Lab reports should be interpreted by a physician in correlation with clinical and radiologic findings
6
(55303-09-07) (55311-16-07)
09/07/2024 16/07/2025
Normal (<5.7 %) Pre-Diabetes (5.7 - 6.4 %) Diabetes (>6.4 %)
Interpretation: According to guidelines of the American Diabetes Association (ADA ) patients already diagnosed with Diabetes Mellitus should monitor HbA1c level as an
indicator of glycemic control over the previous 3 months time. The optimum HbA1c level is based on the health status of the individual.
In conditions associated with an altered relationship between AIC & glycemia, such as hemoglobinopathies including sickle cell discease, pregnancy (second, third trimesters
& the postpartum period), glucose-6-phosphate dehydrogenase deficiency, HIV, haemdialysis, recent blood loss, transfusion or erthropoietin therapy, only plasma blood
glucose criteria should be used to diagnose diabetes.
Lipid Profile
280
Serum Total Cholesterol
202
260
240 240
Cholesterol is essential substance for human body at normal levels. 220
High cholesterol can block blood vessels and can increase the risk of mg/dL
200 202
heart disease or a stroke. 180 Borderline High
160
(55303-09-07) (55311-16-07)
09/07/2024 16/07/2025
Desirable (<200) Borderline High (200 - 240) High (>240)
Serum Triglycerides
406
440
396 406
Triglycerides are fats that are a flexible source of energy. High
triglyceride levels can be treated by following a lower calorie diet, 352 mg/dL
taking regular exercise and medication prescribed by physician.
308
264
300
High
(55303-09-07) (55311-16-07)
09/07/2024 16/07/2025
Normal (<150) Borderline High (150 - 199) High (200 - 499) Very High (=500)
Serum HDL-Cholesterol
38
44
HDL Cholesterol is known as the "Good" cholesterol because it helps
40 40
to remove other forms of cholesterol from bloodstream and
38 mg/dL
associated with a lower risk of heart disease.
36
Low
32
(55303-09-07) (55311-16-07)
09/07/2024 16/07/2025
Low (<39) Normal (>40)
Dr.Mubashar Razzaq Khan
Consultant Pathologist
Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 [email protected] 1 of 3 Saleemi Chowk Satiana Road Faisalabad www.chughtailab.com
Patient Detail: Registration Location: Reference: Patient Number:
Haji Asghar . Doctors Road, Pirmehal Diabetes Care Program 55301-22-10373578
Age/Sex : Registration Date: Consultant: Case Number:
68 (Y) / M 16-Jul-2025 08:51 DR HADI MEERAN HUSSAIN 55311-16-07
Note : Sample Brought to the Lab, , ,
Serum LDL-Cholesterol
108
170
150 149
LDL-C is considered as the primary target of therapy.
Target LDL-C for high risk population according to American Heart 130 mg/dL
Association 2024 guidelines is <55 mg/dL.
Risk stratification is based on clinical history of an individual e.g.
110 108 Above Desirable
ASCVD, diabetes, hypertension, smoking and age. 90
(55303-09-07) (55311-16-07)
09/07/2024 16/07/2025
If you are currently taking a lipid lowering drug, please consult your
physician before changing dosage.
Desirable (<100) Above Desirable (100 - 129) Borderline High (130 - 159) High (160 - 189) Very High (=190)
230
Serum Non-HDL Cholesterol
164
210
200
190
Non-HDL-C is considered as the secondary target of therapy, and
according to American Heart Association 2024 guidelines, target non- 170 mg/dL
164
HDL-C is <100 mg/dL for high risk population.
Risk stratification is based on clinical history of an individual e.g.
150 Borderline High
130
ASCVD, diabetes, hypertension, smoking and age. (55303-09-07) (55311-16-07)
09/07/2024 16/07/2025
If you are currently taking a lipid lowering drug please consult your
physician before changing dosage.
Desirable (<129) Above Desirable (130 - 159) Borderline High (160 - 189) High (190 - 219) Very High (=220)
Renal Function Tests
34
Serum Urea
29
32
30
29
28 mg/dL
26
Normal
24
(55311-16-07)
16/07/2025
Low (<10) Normal (10 - 50) High (>50)
16.5
Serum BUN
14
15.5
14.5
14
13.5 mg/dL
12.5
Normal
11.5
(55311-16-07)
16/07/2025
Low (<8) Normal (8 - 22) High (>22)
Dr.Mubashar Razzaq Khan
Consultant Pathologist
Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
Patient Detail: Registration Location: Reference: Patient Number:
Haji Asghar . Doctors Road, Pirmehal Diabetes Care Program 55301-22-10373578
Age/Sex : Registration Date: Consultant: Case Number:
68 (Y) / M 16-Jul-2025 08:51 DR HADI MEERAN HUSSAIN 55311-16-07
Note : Sample Brought to the Lab, , ,
Serum Creatinine
0.74
0.833
0.777
0.74
0.722 mg/dL
0.666 Normal
(55311-16-07)
16/07/2025
Low (<0.73) Normal (0.73 - 1.18) High (>1.18)
Note: Change in reference values is effective from 7 June 2022.
eGFR
99
110
100 99
ml/min/1.
73 m2
90
Normal
80
(55311-16-07)
16/07/2025
Low (<60) Normal (>60)
Dr.Mubashar Razzaq Khan
Consultant Pathologist
Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
MBBS (Pb) , M. Phil. MBBS , FCPS MBBS ,MCPS ,FCPS. MBBS ,MD, FCAP MBBS , MIAC , M.Phil.,
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic FCPS , FRC PathConsultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 [email protected] 3 of 3 Saleemi Chowk Satiana Road Faisalabad www.chughtailab.com
